Larry Todd Edwards

Larry Todd Edwards has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Arcutis Biotherapeutics, Inc. and Oruka Therapeutics, Inc. The record holds 13 filings, for trades running from 27 September 2023 to 24 August 2026.

On the open market, the record shows 1 purchase worth €7,353 and 6 sales worth €907k. Taken together, the sales exceed the purchases by €900k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 6 share grants. So far in 2026, the count stands at no purchases and 1 sale.

The latest filing, published on 25 August 2026, reports a share grant in Oruka Therapeutics, Inc. The clock since the last published purchase (3 December 2024) now reads 684 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.